PIAZZA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.394
EU - Europa 2.004
AS - Asia 1.389
OC - Oceania 10
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 2
Totale 13.810
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.378
IT - Italia 818
CN - Cina 733
SG - Singapore 486
DE - Germania 281
FI - Finlandia 216
SE - Svezia 151
GB - Regno Unito 119
UA - Ucraina 110
FR - Francia 106
RU - Federazione Russa 106
IN - India 79
VN - Vietnam 41
NL - Olanda 38
IE - Irlanda 21
JP - Giappone 15
CA - Canada 14
HK - Hong Kong 12
ES - Italia 10
AU - Australia 8
PL - Polonia 8
EU - Europa 5
TR - Turchia 5
TW - Taiwan 5
BG - Bulgaria 4
CL - Cile 4
IR - Iran 4
DK - Danimarca 3
SA - Arabia Saudita 3
GR - Grecia 2
MK - Macedonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
BE - Belgio 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
ZA - Sudafrica 1
Totale 13.810
Salva come PNG Salva come JPEG
Città #
Fairfield 1.544
Woodbridge 1.012
Ann Arbor 953
Chandler 854
Houston 762
Ashburn 761
Cambridge 574
Seattle 563
Wilmington 499
Jacksonville 489
Singapore 384
Boardman 248
Santa Clara 224
Padova 203
Princeton 195
San Diego 174
Beijing 160
Medford 126
Helsinki 104
Nanjing 94
Des Moines 92
Guangzhou 78
Pune 54
Milan 51
New York 47
Dong Ket 41
Roxbury 34
Shenyang 30
Jinan 28
Shanghai 26
Hebei 25
Nanchang 24
London 22
Changsha 20
Bologna 18
Redwood City 17
Verona 17
Los Angeles 16
Dublin 15
Naples 15
Tianjin 15
Rome 14
Dallas 13
Jiaxing 12
Malo 12
Norwalk 12
Vicenza 11
Frankfurt am Main 10
Hong Kong 10
Kharkiv 10
Lappeenranta 10
Falls Church 9
Phoenix 9
Amsterdam 8
Borås 7
Hefei 7
Kunming 7
Ogden 7
Taizhou 7
Madrid 6
Nürnberg 6
Shibuya 6
Taiyuan 6
Turin 6
Venezia 6
Indiana 5
Kilburn 5
Kyoto 5
Mountain View 5
Ningbo 5
Nuremberg 5
Paris 5
Rockville 5
Treviso 5
Venice 5
Vittorio Veneto 5
Bolzano 4
Chicago 4
Florence 4
Hounslow 4
Munich 4
North York 4
Pignone 4
San Giovanni Lupatoto 4
Sofia 4
Washington 4
Zhengzhou 4
Ahmedabad 3
Bassano del Grappa 3
Bournemouth 3
Bussolengo 3
Cervignano del Friuli 3
Falkenstein 3
Forest City 3
Hangzhou 3
Hanover 3
Isola della Scala 3
Istanbul 3
Ladispoli 3
Lonigo 3
Totale 10.957
Salva come PNG Salva come JPEG
Nome #
R-Vemp Is a Safe and Effective Chemo-Immunotherapeutic Regimen In Elderly Unfit DLBCL Patients: Report From a Single Center-Experience 484
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma 193
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation 174
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 174
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis 165
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 161
The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma 156
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 155
Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia 149
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia 141
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 139
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 139
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 135
Possible neuroleukemiosis in two patients with acute myeloid leukemia in complete bone marrow remission 134
Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: A report of three cases 134
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 132
Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients. 132
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 131
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 130
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 129
Protein Kinase CK2 Inhibition Down Modulates the NF-κB and STAT3 Survival Pathways, Enhances the Cellular Proteotoxic Stress and Synergistically Boosts the Cytotoxic Effect of Bortezomib on Multiple Myeloma and Mantle Cell Lymphoma Cells 128
Towards a new age in the treatment of multiple myeloma 127
Comparative Analysis of NK Receptor and T-Cell Receptor Repertoires in Patients with Chronic Myeloid Leukemia Treated with Different Tyrosine Kinase Inhibitors 125
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome 124
Serine-Threonine protein kinases CK1, CK2 and GSK3 in normal and malignant haematopoiesis 121
Targeting CK2-driven non-oncogene addiction in B-cell tumors 120
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 120
Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research 120
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia 119
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas 117
In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment 117
Inhibition of protein kinase CK2 with the clinical-grade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity 115
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia 115
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 114
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study 114
Cytogenetic Impact on Lenalidomide Treatment in Relapsed/Refractory Multiple Myeloma: A Real-Life Evaluation 113
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 112
CX-4945, a selective inhibitor of casein kinase 2, synergizes with B cell receptor signaling inhibitors in inducing diffuse large B cell lymphoma cell death 111
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine 111
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 108
Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death 108
Modeling acute promyelocytic leukemia in the mouse: new insights in the pathogenesis of human leukemias. 107
Analysis of Wnt and Hedgehog Pathways Regulating Protein Kinases CK1 and CK2 in Acute Myeloid Leukemia Cells and Stem Cells: Correlation with the Expression of Wnt and Hedgehog Targets and Biological and Clinical Features 107
Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and ß-catenin survival signaling pathways 106
Bone marrow stromal cell-fueled multiple myeloma growth and osteoclastogenesis are sustained by protein kinase CK2 105
Role of protein kinase CK2 in the retinoic acid-induced differentiation of acute promyelocytic leukemia cells. 102
Effects of CK2 inhibition on multiple signaling pathways in myeloma cells. 102
Protein kinase CK2 protects multiple myeloma cells from ER stress-induced apoptosis and from the cytotoxic effect of HSP90 inhibition through regulation of the unfolded protein response 101
Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases 100
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy 99
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis 98
Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes 95
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature 95
Hyperforin blocks neutrophil activation of MMP-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis 94
Role of GSK3 in multiple myeloma cell growth and survival 94
Inhibition of leukocyte elastase, polymorphonuclear chemoinvasion, and inflammation-triggered pulmonary fibrosis by a 4-alkyliden-beta-lactam with a galloyl moiety 94
B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation 94
Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma 94
Peripheral nervous system involvement in lymphomas 94
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficiencies 93
Protein kinase CK2 is widely expressed in follicular, Burkitt and diffuse large B-cell lymphomas and propels malignant B-cell growth. 91
Old and young actors playing novel roles in the drama of multiple myeloma bone marrow microenvironment dependent drug resistance 91
CK2 Kinase Inhibitors Display Anti-Myeloma Effects and Antagonize Osteoclast Activity in Models of Multiple Myeloma Bone Marrow Microenvironment 90
Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes 90
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis 90
Modulation of ER Stress/Unfolded Protein Response (UPR) Pathways in Multiple Myeloma Cells by Inhibition of Hsp90 and Serine-Threonine Kinase CK2. 89
A SCORING SYSTEM TO PREDICT THE RISK OF ATRIAL FIBRILLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA 89
Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process 88
New responsibilities for aged kinases in B-lymphomas 88
Signalling molecules as selective targets for therapeutic strategies in multiple myeloma 87
Expression and functional role of chemokine receptors in multiple myeloma 86
Multiple myeloma cell survival relies on high activity of protein kinase CK2 85
Multiple myeloma cells survival and proliferation rely on high levels and activity of the serine-threonine kinase CK2. 85
NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias 85
Protein kinase CK2 in normal and malignant hematopoiesis 84
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. 82
Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction 81
Treatment Induced Cytotoxic T-Cell Modulation in Multiple Myeloma Patients 80
Lymph node core needle biopsy in lymphoproliferative disorders - Authors' reply to Al-Abbadi and colleagues 79
Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis 78
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma 77
Expression and functional role of chemokine receptors in multiple myeloma 76
Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity 76
Cytokines, chemokines and other biomolecular markers in sarcoidosis 75
Lymph node core needle biopsy for the diagnosis of lymphoproliferative disorders: a word of caution 75
Multiple myeloma cells survival and proliferation rely on high levels and activity of the serine-threonine kinase CK2. 75
PLZF controls the homeostasis of the hemopoietic stem cell compartment. 74
Prognostic value of heavy-chain gene mutation status and ZAP-70 expression in 113 CLL patients from a single institution 74
Expression and functional role of CXCR3 on malignant B cells from patients with B-cell chronic disorders 73
Inhibition of protein kinase CK2 affects the homeostasis of the unfolded protein response pathways in multiple myeloma cells and empowers the cytotoxic effect of Hsp90 inhibitors 72
The theory of APL. 72
Targeted disruption of the PLZF APL-associated gene homologue, PLZP, in the mouse. 71
The chemokine receptor CXCR3 is expressed on malgnat B cells and mediates chemotaxis. 71
Pokemon is required for terminal differentiation in multiple tissues. 70
Expression and functional properties of costimulatory molecules in patients with B cell chronic lymphoproliferative disorders. 70
Pokemon is essential for terminal myeloid and erythroid differentiation. 69
Novel players in multiple myeloma pathogenesis: role of protein kinases CK2 and GSK3. 69
Rituximab, Bendamustine and Cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 69
Characterization of PLZP, a novel PLZF-related factor. 68
Bortezomib-Dexamethasone As Inducion Therapy for Light Chain Deposition Disease (LCDD): A Single Center Experience 67
Totale 10.781
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.506
article - articoli 49.224
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.064
Totale 107.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.381 0 0 0 0 0 0 203 266 230 300 222 160
2020/20212.332 168 168 160 221 40 93 170 185 292 419 256 160
2021/20222.166 131 244 224 104 131 142 100 242 125 47 248 428
2022/20231.844 345 171 43 258 278 209 27 130 226 27 95 35
2023/20241.166 41 116 117 85 113 182 99 52 37 100 102 122
2024/20251.576 26 326 230 180 529 165 120 0 0 0 0 0
Totale 14.055